NCT03922269Completed
Trans People Living With HIV Throughout Europe
Source: ClinicalTrials.gov · Last updated 23 Dec 2025
Brief summary (registry, in English)
The project will study a European cohort of individuals identifying themselves as transgender or non-binary and living with HIV. The study will collect both qualitative data on this cohort and clinical data over an 18 month period. The study will investigate the success of HIV treatment for this cohort through the primary outcome measure of HIV viral load recorded in routine blood tests. The results from this study will assist in informing future HIV treatment guidelines on the monitoring of HIV infection in transgender and non-binary individuals and assisting in the design of future interventional studies within this population.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 200 (actual)
- First submitted
- 17 Apr 2019
- Start date
- 11 Oct 2019
- Primary completion date
- 17 Dec 2025
- Lead sponsor
- Chelsea and Westminster NHS Foundation Trust
- Diseases
- HIV
- NCT number
- NCT03922269
What you commit to
- Study type: Observational
- Participants enrolled: 200
- From 11 Oct 2019 to the primary completion date, 17 Dec 2025
- 4 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age \< 18 years
Other
- Unable to take part in the study according to the Investigator opinion (example: unable to understand the study information leaflet, unable to provide written consent, etc.)
Who the study is looking for
- Participant self-identifies as transgender and/or has a current gender identity which differs from gender assigned at birth (includes all gender diverse people)
- Age \> 18 years
- HIV infection diagnosis at any time before study consent
- Having been prescribed antiretroviral therapy at any time (including people for who antiretroviral therapy initiation is planned after study enrolment)
- Willing to sign an informed consent and take part in the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Elton John Centre, Brighton and Sussex University Hospitals Coordinator of this site? Confirm its status | Brighton | United Kingdom | Unknown status |
| Chelsea And Westminster Hospital Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
| Manchester University NHS Foundation Trust Coordinator of this site? Confirm its status | Manchester | United Kingdom | Unknown status |
| Servizio Sanitario Nazionale Regione Piemonte Azienda Sanitaria Locale "Citta di Torino" Department of Medical Sciences, University of Turin Coordinator of this site? Confirm its status | Torino | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.